Ignite Creation Date:
2024-05-06 @ 8:29 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02742051
Status:
COMPLETED
Last Update Posted:
2021-09-23
First Post:
2016-04-07
Brief Title:
A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive HER2-negative Breast Cancer
Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization Data
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Class:
OTHER
Study ID:
50102016015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Lead Sponsor Class:
OTHER
Responsible Party:
Jieqiong Liu MD PhD
Responsible Party Title:
Attending Surgeon of Breast Tumor Center
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Old Name:
None
Old Organization:
None